PodParley PodParley
PodParley
Substantial and Durable Overall and Intracranial Activity of Trastuzumab Deruxtecan in Previously Treated HER2-positive mBC Including a Large Cohort of Patients with Brain Metastases episode artwork

EPISODE · Oct 24, 2024 · 6 MIN

Substantial and Durable Overall and Intracranial Activity of Trastuzumab Deruxtecan in Previously Treated HER2-positive mBC Including a Large Cohort of Patients with Brain Metastases

from Medical Digest & Congress Report · host Medical Congress News

Professor Giampaolo Bianchini shares his insights on the DESTINY-Breast12 study. Video: https://medicaldigest.org/scientific-contents/interview:substantial-and-durable-overall-and-intracranial-activity-trastuzumab-deruxtecan-previously-treated-her2-positive-mbc-including-large-cohort-patients-brain-metastases

Episode metadata supplied by the publisher feed · Published Oct 24, 2024

Embed this episode

Ready to play

Substantial and Durable Overall and Intracranial Activity of Trastuzumab Deruxtecan in Previously Treated HER2-positive mBC Including a Large Cohort of Patients with Brain Metastases

0:00 6:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 6 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on October 24, 2024.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!